1887
Volume 2021, Issue 3
  • ISSN: 1999-7086
  • EISSN: 1999-7094

Abstract

Inflammation and pain are normally present concomitantly, which requires using a combination of anti-inflammatory and pain killer medications. This could potentially decrease patient adherence to such combinations. Therefore, there is an urgent need to develop combinations of anti-inflammatory and analgesic therapies. This study is designed to evaluate the analgesic and anti-inflammatory activities of a newly synthetic compound of ibuprofen and gabapentin. The study protocol includes two stages. The first stage: the evaluation of the analgesic effectiveness of tested compounds via using hot plate and acetic acid induced-writhing tests. The second stage: the investigation of the anti-inflammatory activity via using dextran induced- peritonitis, cotton pelt induced- granulomas, and formalin induced- paw edema analyses. Rats were randomly divided into four groups (six rats in each group): Group A (control): rats were orally treated with vehicle (propylene glycol 50 % v/v); Group B: rats were orally treated with ibuprofen (10 mg/ kg); Group C: rats were orally treated with gabapentin (200 mg/ kg); and Group D: rats were orally treated with the synthetic compound (ibuprofen-gabapentin) in dose equivalent to 10 mg/ kg ibuprofen and 200 mg/kg gabapentin. It was found that the newly synthesized compound of ibuprofen and gabapentin has significantly reduced the pain in comparison with control groups. Additionally, this compound has significant anti-inflammatory properties compared to medications admitted to the control group as well. The newly synthesized compound (ibuprofen-gabapentin) demonstrates remarkable analgesic and anti-inflammatory activities in comparison with the conventional compounds.

Loading

Article metrics loading...

/content/journals/10.5339/jemtac.2021.24
2021-10-19
2021-12-02
Loading full text...

Full text loading...

/deliver/fulltext/jemtac/2021/3/jemtac.2021.24.html?itemId=/content/journals/10.5339/jemtac.2021.24&mimeType=html&fmt=ahah

References

  1. Kaur S, Reddy KV. Bijjem et al. Anti-inflammatory and antihyperalgesic effects of the combination of ibuprofen and hemin in adjuvant-induced arthritis in the Wistar rat. Inflammopharmacol; 2011; 19:265–272.
    [Google Scholar]
  2. Bennett MI, Simpson KH. Gabapentin in the treatment of neuropathic pain. Palliat Med. 2004; 185–11.
    [Google Scholar]
  3. Cheng JK, Chen CC, Yang JR, Chiou LC. The antiallodynic action target of intrathecal gabapentin: Ca2+ channels, KATP channels or N-methyl-d-aspartic acid receptors? Anesth Analg. 2006; 102182–187.
    [Google Scholar]
  4. Hama A, Sagen J. Behavioral characterization and effect of clinical drugs in a rat model of pain following spinal cord compression. Brain Res. 2007; 1185117–128.
    [Google Scholar]
  5. Munro G, Erichsen HK, Mirza NR. Pharmacological comparison of anticonvulsant drugs in animal models of persistent pain and anxiety. Neuropharmacology. 2007; 53609–618.
    [Google Scholar]
  6. Joshi SK, Hernandez G, Mikusa JP, Zhu CZ, Zhong C, Salyers A, Wismer CT, Chandran P, Decker MW, Honore P. Comparison of antinociceptive actions of standard analgesics in attenuating capsaicin and nerve-injury induced mechanical hypersensitivity. Neuroscience. 2006; 143587–596.
    [Google Scholar]
  7. Hasnie FS, Breuer J, Parker S, Wallace V, Blackbeard J, Lever I, Kinchington PR, Dickenson AH, Pheby T, Rice AS. Further characterization of a rat model of varicella zoster virus-associated pain: Relationship between mechanical hypersensitivity and anxiety related behavior, and the influence of analgesic drugs. Neuroscience. 2007; 1441495–1508.
    [Google Scholar]
  8. Backonja M, Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M, LaMoreaux L, Garofalo E. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA. 1998; 2801831–1836.
    [Google Scholar]
  9. Singh D, Kennedy DH. The use of gabapentin for the treatment of postherpetic neuralgia. Clin Ther. 2003; 25:852-889.
    [Google Scholar]
  10. Pöllmann W, Feneberg W. Current management of pain associated with multiple sclerosis. CNS Drugs. 2008; 22291–324.
    [Google Scholar]
  11. Newshan G. HIV neuropathy treated with gabapentin. AIDS. 1998; 12219–221.
    [Google Scholar]
  12. Berger A, Dukes E, Mercadante S, Oster G. Use of antiepileptics and tricyclic antidepressants in cancer patients with neuropathic pain. Eur J Cancer Care. 2006; 15138–145.
    [Google Scholar]
  13. Crofford LJ. Pain management in fibromyalgia. Curr Opin Rheumatol. 2008; 20246–250.
    [Google Scholar]
  14. Gray P, Williams B, Cramond T. Successful use of gabapentin in acute pain management following burn injury: a case series. Pain Med. 2008; 9371–376.
    [Google Scholar]
  15. Tan AK, Duman I, TaÅŸkaynatan MA, Hazneci B, Kalyon TA. The effect of gabapentin in earlier stage of reflex sympathetic dystrophy. Clin Rheumatol. 2007; 26561–565.
    [Google Scholar]
  16. Maneuf YP, Luo ZD, Lee K. alpha2delta and the mechanism of action of gabapentin in the treatment of pain. Semin Cell Dev Biol. 2006; 17565–570.
    [Google Scholar]
  17. Omar M.E. Abdel-Salam*, Amany A. Sleem. Study of the analgesic, anti-inflammatory, and gastric effects of gabapentin. Drug Discov Ther. 2009; 3:(1):18–26.
    [Google Scholar]
  18. Monther Faisal Mahdi and Hiba Najeh Alsaad. Design, Synthesis and Hydrolytic Behavior of Mutual Prodrugs of NSAIDs with Gabapentin Using Glycol Spacers. Pharmaceuticals 2012, 5, 1080–1091.
    [Google Scholar]
  19. Chidambarann Suthakaran1, Gopalakrishnan Senthil. Evaluation of analgesic and anti-inflammatory activity of a combination of ibuprofen-pregabalin in animal models of pain and inflammation. Clinical and Diagnostic Research J. 2018; Vol-12:(9): FC05–FC08.
    [Google Scholar]
  20. Yi Feng, M.D.,* Minglei Cui, Ph.D.,† William D. Willis, M.D., Ph.D.‡ Gabapentin Markedly Reduces Acetic Acid–induced Visceral Nociception. Anesthesiology 2003; 98:729–33.
    [Google Scholar]
  21. Ahmed A. Fadda, Khaled M. Elattar. Design and Synthesis of Some Enaminonitrile Derivatives of Antipyrine as Potential Novel Anti-Inflammatory and Analgesic Agents. Journal of Biosciences and Medicines, 2015. Vol.3: No.11.
    [Google Scholar]
  22. Onasanwo SA and Elegbe RA. Anti-nociceptive and anti-inflammatory properties of the leaf extracts of Hedranthera barteri in rats and mice. African Journal of Biomedical Research, 2006; (9); 109–117.
    [Google Scholar]
  23. Julieta Rodini Engracia Moraes,Flávio Ruas de Moraes,Gervasio Henrique Bechara. Participation of macrophages in chloramphenicol-potentiated carrageenin-induced peritonitis in rats. Brazilian Journal of Medical and Biological Research. 1993; 26:(5):497–507.
    [Google Scholar]
  24. Waleed K. G. Al-Hejjaj, Intesar T. Numan, Raghdan Z. Al-Sa'ad, and Saad A. Hussain. Anti-inflammatory activity of telmisartan in rat models of experimentally-induced chronic inflammation: Comparative study with dexamethasone. Saudi Pharm J. 2011; 19:(1):29–34.
    [Google Scholar]
  25. M. Saradha, S. Paulsamy. Antinociceptive and antiinflammatory activities of stem bark of an endangered medicinal plant, hildegardia populifolia (ROXB.) schott and endl. International Journal of Pharma and Bio Sciences. 2013; 4:(3):P30–P36.
    [Google Scholar]
  26. Kilo S, Forster C, Geisslinger G, et al (1995) Inflammatory models of cutaneous hyperalgesia are sensitive to effects of ibuprofen in man. Pain 62:187–193.
    [Google Scholar]
  27. Kean WF, Buchanan WW, Rainsford KD (1999) Therapeutics of ibuprofen in rheumatic and other chronic and painful diseases. In: Rainsford KD (ed) Ibuprofen, a critical bibliographic review. Taylor & Francis, London, pp 279–353.
    [Google Scholar]
  28. Rainsford KD (2009) Ibuprofen: pharmacology, efficacy and safety. Inflammopharmacol 17:275–342.
    [Google Scholar]
  29. Hendrich J, Van Minh AT, Heblich F, Nieto-Rostro M, Watschinger K, Striessnig J, Wratten J, Davies A, Dolphin AC. Pharmacological disruption of calcium channel trafficking by the alpha2 delta ligand gabapentin. Proc Natl Acad Sci U S A. 2008; 1053628–3633.
    [Google Scholar]
  30. Fehrenbacher JC, Taylor CP, Vasko MR. Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C. Pain. 2003; 105133–141.
    [Google Scholar]
  31. Coderre TJ, Kumar N, Lefebvre CD, Yu JSC. Evidence that gabapentin reduces neuropathic pain by inhibiting the spinal release of glutamate. J Neurochem. 2005; 941131–1139.
    [Google Scholar]
  32. Tanabe M, Takasu K, Kasuya N, Shimizu S, Honda M, Ono H. Role of descending noradrenergic system and spinal alpha2-adrenergic receptors in the effects of gabapentin on thermal and mechanical nociception after partial nerve injury in the mouse. Br J Pharmacol. 2005; 144703–714.
    [Google Scholar]
  33. Eun-MiChoiJae-KwanHwang. Antiinflammatory, analgesic and antioxidant activities of the fruit of Foeniculum vulgare. Fitoterapia. 2004, (7)557–565.
    [Google Scholar]
  34. Suh, H.H., Fujimoto, J.M., Tseng, L.F., 1992. Different radiant heat intensities diferentiate intracerebroventricular morphine from bendorphin-induced inhibition of the tail-lick response in the mouse. Eur. J. Pharmacol. 213, 337–341.
    [Google Scholar]
  35. Kean WF, Buchanan WW, Rainsford KD (1999) Therapeutics of ibuprofen in rheumatic and other chronic and painful diseases. >In: Rainsford KD (ed) Ibuprofen, a critical bibliographic review. Taylor & Francis, London, pp 279–353.
    [Google Scholar]
  36. Shamsherjit Kaur,Krishna Reddy V. Bijjem, Pyare Lal Sharma. Anti-inflammatory and antihyperalgesic effects of the combination of ibuprofen and hemin in adjuvant-induced arthritis in the Wistar rat. Inflammopharmacol. 2011; 19:265–272.
    [Google Scholar]
  37. Governo RJ, Morris PG, Marsden CA, Chapman V. Gabapentin evoked changes in functional activity in nociceptive regions in the brain of the anaesthetized rat: an fMRI study. Br J Pharmacol. 2008; 1531558–1567.
    [Google Scholar]
  38. Kazi JA, Gee CF. Gabapentin completely attenuated the acute morphine induced c-Fos expression in the rat striatum. J Mol Neurosci. 2007; 3247–52.
    [Google Scholar]
  39. Okoli, C., Akah, P., Onuoha, N., Okoye, T., Nwoye, A., Nworu, C., 2008. Acanthus montanus: an experimental evaluation of the antimicrobial, anti-inflammatory and immunological properties of a traditional remedy for furuncles. BMC Complement Altern. Med. 8, 27–37.
    [Google Scholar]
  40. Hua, X., Chen, P., Fox, A., Myers, R., 1996. Involvement of cytokines in lipopolysaccharide-induced facilitation of CGRP release from capsaicin-sensitive nerves in the trachea: studies with interleukin-1b and tumor necrosis factor-a. J. Neurosci. 16 (15), 4742–4748.
    [Google Scholar]
  41. Yoshida, T., Yamagishi, S., Nakamura, K., Matsui, T., Imaizum, T., et al., 2006. Telmisartan inhibits AGE-induced C-reactive protein production through down regulation of the receptor for AGE via PPAR-c activation. Diabetologia 49, 3094–3099.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/jemtac.2021.24
Loading
/content/journals/10.5339/jemtac.2021.24
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error